Found 6 matching trials
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer PHASE2 The hypo-FLAME study is a multicenter phase II study (n=100) to investigate...
Show More Learn More & Join Trial
Androgen-responsive POSLUMA-guided Intra-prostatic Boost PHASE2 This research study is for men with intermediate- or high-risk prostate can...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 PHASE2 The hypo-FLAME 2.0 study is a multicenter phase II study (n=124) investigat...
Show More Status
Active Not Recruiting
Location
University Hospitals Leuven
Learn More & Join Trial
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer PHASE2 The goal of this clinical trial is to determine the safety of stereotactic ...
Show More Location
Lombardi Comprehensive Cancer Center, Georgetown University
Learn More & Join Trial
Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer NA EBRT is one of the standard treatment options for patients with localized P...
Show More Status
Active Not Recruiting
Location
Netherlands Cancer Institute
Learn More & Join Trial
Dose Escalation For INtraprostatic LEsions PHASE2 External beam radiotherapy combined with androgen deprivation therapy is a ...
Show More Location
The Ottawa Hospital Cancer Centre
Learn More & Join Trial